LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 83RD LEGISLATIVE REGULAR SESSION April 12, 2013 TO: Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services FROM: Ursula Parks, Director, Legislative Budget Board IN RE:SB316 by Uresti (Relating to continuing education for pharmacists regarding drug abuse and opioid drugs and an interim study regarding opioid abuse.), Committee Report 1st House, Substituted No significant fiscal implication to the State is anticipated. The bill would amend the Occupations Code to require the Board of Pharmacy to develop a continuing education program regarding opioid drug abuse and the delivery, dispensing, and provision of tamper-resistant opioid drugs after considering the input from interested persons and may by rule to require a license holder to satisfy continuing education requirements through attendance of these programs. The bill would also require the standing committee of the Senate that has primary jurisdiction over health and human services to conduct an interim study regarding opioid abuse and the provision of tamper-resistant opioids. Based on information provided by the Board of Pharmacy, it is assumed that duties and responsibilities associated with implementing the provisions of the bill could be accomplished utilizing existing resources. Local Government Impact No fiscal implication to units of local government is anticipated. Source Agencies:515 Board of Pharmacy LBB Staff: UP, CL, MW, ED
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 83RD LEGISLATIVE REGULAR SESSION
April 12, 2013
TO: Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services FROM: Ursula Parks, Director, Legislative Budget Board IN RE:SB316 by Uresti (Relating to continuing education for pharmacists regarding drug abuse and opioid drugs and an interim study regarding opioid abuse.), Committee Report 1st House, Substituted
TO: Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services
FROM: Ursula Parks, Director, Legislative Budget Board
IN RE: SB316 by Uresti (Relating to continuing education for pharmacists regarding drug abuse and opioid drugs and an interim study regarding opioid abuse.), Committee Report 1st House, Substituted
Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services
Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services
Ursula Parks, Director, Legislative Budget Board
Ursula Parks, Director, Legislative Budget Board
SB316 by Uresti (Relating to continuing education for pharmacists regarding drug abuse and opioid drugs and an interim study regarding opioid abuse.), Committee Report 1st House, Substituted
SB316 by Uresti (Relating to continuing education for pharmacists regarding drug abuse and opioid drugs and an interim study regarding opioid abuse.), Committee Report 1st House, Substituted
No significant fiscal implication to the State is anticipated.
No significant fiscal implication to the State is anticipated.
The bill would amend the Occupations Code to require the Board of Pharmacy to develop a continuing education program regarding opioid drug abuse and the delivery, dispensing, and provision of tamper-resistant opioid drugs after considering the input from interested persons and may by rule to require a license holder to satisfy continuing education requirements through attendance of these programs. The bill would also require the standing committee of the Senate that has primary jurisdiction over health and human services to conduct an interim study regarding opioid abuse and the provision of tamper-resistant opioids. Based on information provided by the Board of Pharmacy, it is assumed that duties and responsibilities associated with implementing the provisions of the bill could be accomplished utilizing existing resources.
The bill would amend the Occupations Code to require the Board of Pharmacy to develop a continuing education program regarding opioid drug abuse and the delivery, dispensing, and provision of tamper-resistant opioid drugs after considering the input from interested persons and may by rule to require a license holder to satisfy continuing education requirements through attendance of these programs. The bill would also require the standing committee of the Senate that has primary jurisdiction over health and human services to conduct an interim study regarding opioid abuse and the provision of tamper-resistant opioids.
Based on information provided by the Board of Pharmacy, it is assumed that duties and responsibilities associated with implementing the provisions of the bill could be accomplished utilizing existing resources.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies: 515 Board of Pharmacy
515 Board of Pharmacy
LBB Staff: UP, CL, MW, ED
UP, CL, MW, ED